Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 5
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
Brigitte Michelsen, Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Lykke Midtbøll Ørnbjerg, Jakub Závada, Bente Glintborg, Douglas Alan Macdonald, Žiga Rotar
Izvirni znanstveni članek
Oznake: zdravstvena politika;psoriatični artritis;aksialni spondiloartritis;priporočila za zdravljenje;health policy;psoriatic arthritis;axial spondyloarthritis;treatment recommendations;
This is the first report comparing EULAR and national treatment recommendations for PsA patients across Europe, and the first this decade to compare ASAS-EULAR and national treatment recommendations in axSpA patients. An electronic survey was completed from October 2021–April 2022 by rheumatologists ...
Leto: 2023 Vir: Medicinska fakulteta (UL MF)
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
Brigitte Michelsen, Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Lykke M. Ørnbjerg, Pavel Horák, Bente Glintborg, Douglas Alan Macdonald, Karin Laas, Žiga Rotar, Matija Tomšič
Pregledni znanstveni članek
Oznake: access to health care;axial spondyloarthritis;biologic therapy;health policy;psoriatic arthritis;socioeconomic health disparties;
Background: Studies on national policies for biologics are warranted. Objectives: To map and compare national healthcare set-ups for prescription, start, switch, tapering, and discontinuation of biologic/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in patients with psoriatic art ...
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Zohra Faizy Ahmadzay, Bente Glintborg, Jette Heberg, Sara Nysom Christensen, Simon Horskjær Rasmussen, Anne Gitte Loft, Isabel Castrejón, Žiga Rotar, Katja Perdan-Pirkmajer
Izvirni znanstveni članek
Oznake: bDMARD;epidemiology;spondyloarthritis;
Objectives: In axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating secukinumab, we aimed to assess retention rates and proportions of patients achieving remission and low disease activity (LDA), according to disease activity measures and patient-reported outcomes at 24 ...
Leto: 2025 Vir: Medicinska fakulteta (UL MF)
ǂThe ǂimpact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis
Zohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, Bente Glintborg, Marion Pons, Katja Perdan-Pirkmajer, Jette Heberg, Signe Møller-Bisgaard, Sara Nysom Christiansen, Simon Horskjær Rasmussen, Anne Gitte Loft, Žiga Rotar
Izvirni znanstveni članek
Oznake: psoriatic arthritis;Secukinumab;real-world data;European health registries;rheumatology;
Objectives: In patients with psoriatic arthritis (PsA) initiating treatment with secukinumab, we investigated the impact of smoking and body mass index (BMI) on secukinumab retention rate at 12 months and the achievement of low Disease Activity Index for PsA in 28 joints (DAPSA28 ≤14) at 6 months. M ...
Leto: 2026 Vir: Repozitorij Univerze v Ljubljani (RUL)
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
Zohra Faizy Ahmadzay, Zohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Kasper Jensen, Jacob Brauner Jørgensen, Jette Heberg, Anne Gitte Loft, Brigitte Michelsen, Gareth T. Jones, Pasoon Hellamand, Žiga Rotar, Katja Perdan-Pirkmajer
Izvirni znanstveni članek
Oznake: biological therapy;cardiovascular disease;DMARD;hypertension;psoriatic arthritis;
Objectives: To investigate associations between cardiometabolic comorbidities and clinical characteristics, prescription patterns and retention of first biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) in patients with psoriatic arthritis (PsA). Methods: Patients with Ps ...
Leto: 2026 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 5
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: